Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 2/20 | 0.59 |
| ▸ | CTSL | P07711 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | CTSS | P25774 | 1/20 | 0.59 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | MMP14 | P50281 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6425913 | 0.85 | MAPT (0.58) | PTPRCCTSLPTPN1CTSSPTPN13 | |
| SCHEMBL6420464 | 0.85 | MEN1 (0.51) | PTPRCCTSLPTPN1CTSSPTPN13 | |
| SCHEMBL6422899 | 0.84 | MEN1 (0.50) | PTPRCCTSLPTPN1CTSSPTPN13 | |
| SCHEMBL11293785 | 0.82 | PTPRC (0.51) | PTPRCCTSLPTPN1CTSSPTPN13 | |
| SCHEMBL11291969 | 0.82 | PTPRC (0.51) | PTPRCCTSLPTPN1CTSSPTPN13 | |
| SCHEMBL14355330 | 0.81 | ALDH1A1 (0.57) | MEN1KMT2AHTTMMP14LMNA | |
| SCHEMBL6421532 | 0.81 | CASP3 (0.65) | MEN1KMT2AMMP14LMNARAB9A | |
| SCHEMBL4585595 | 0.81 | HTT (0.61) | PTPRCHTTLMNAMAPT | |
| SCHEMBL6420621 | 0.79 | MEN1 (0.51) | PTPRCMEN1KMT2AHTTMMP14 | |
| SCHEMBL22033363 | 0.79 | POLB (0.66) | MEN1KMT2ATDP1HTTKCNMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009924-A1 | Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives | HUANG HSU-SHAN (TW) | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009924-A1 | Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives | NFE2L2, NR2F2, TFAM | PTPRC 3438/4885CTSL 635/4885PTPN1 3824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.